Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:
Robert B. Parker, PharmD
Department of Pharmacy
University of Tennessee College of Pharmacy
• Dr Parker reports grants/research support from AstraZeneca Pharmaceuticals; and serving as a consultant to Pfizer Inc.
Marc Cohen, MD
Chief of the Division of Cardiology
Newark Beth Israel Medical Center
Newark, New Jersey
• Dr Cohen reports grants/research support from Aventis, Merck and Company, and Schering.
Sarah A. Spinler, PharmD
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Coronary Intensive Care Unit
University of Pennsylvania Medical Center
• Dr Spinler reports serving as a consultant to Sanofi-Aventis.
Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that one or more articles in this continuing pharmaceutical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. The following faculty members have disclosed that their articles have referenced the following unlabeled/unapproved uses of drugs or devices:
Dr Spinler—percutaneous coronary intervention.
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.
Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.